Skip to content

LUMINA : Measure the Effectiveness of the Booklet Named Comprendre Les Essais Cliniques

LUMINA : Measure the Effectiveness of the Booklet Named Comprendre Les Essais Cliniques With Patients Included or Not Included in Clinical Trials Within the Clinical Neurosciences - Rheumatology Pole of the CHU de Nice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05388344
Acronym
LUMINA
Enrollment
50
Registered
2022-05-24
Start date
2021-10-15
Completion date
2021-12-15
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic

Brief summary

Various studies have shown that many patients do not understand all the information provided by the study investigator and by the information sheet before entering a clinical research protocol. Many materials has been developped in previous research, trying to improve patients' understanding. Nonetheless, their effectiveness remains uncertain. The LUMINA project aims to measure the effectiveness of the booklet named Comprendre les essais cliniques with patients included or not included in clinical trials within the Clinical Neurosciences - Rheumatology pole of the CHU de Nice. The design of this study is before/after. A questionnaire was submitted to the patients before and after reading the booklet. That method is used in order to show if there was a difference between the score obtained from the questionnaire before and after reading. This difference could reflect an improvement in patients' comprehension and, by extension, the effectiveness of the support the team developed.

Interventions

OTHERBooklet reading

Submission of the questionnaire before and after booklet reading

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* age \<18 * patient coming for a consultation or an hospitalization within the Clinical Neurosciences-Rheumatology pole of the CHU de Nice, or companions/caregivers who helps the patients understand * Patient able to read and to understand the french language, * Patient included or not in clinical trials.

Exclusion criteria

* Participants unable to read * Patient unable to understand the french language

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the effectiveness of the bookletday 1Measurement of the score (0 to 13)obtained from the assessment questionnaire (right or wrong) created for the study, before and after reading the booklet right = 1 point, wrong = 0 point . Score: points addition

Secondary

MeasureTime frameDescription
Assess the booklet's lisibilityday 1Calculate the Flesch Reading ease index of the booklet
Assess the difference in understanding between patient groupsday 1Measurement of the impact of different variables, such as age, sex, pathology, on the questionnaire score by using statistical tests
Measurement of the patients' satisfactionday 1Calculation of the satisfaction rate by using a satisfaction survey
Assess the booklet comprehensionday 1number of responses

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026